Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-06425090 lot consistency study in healthy older adults
NCT03579459Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jul 2018
- Primary completion
- Aug 2019
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Clostridium difficile vaccine in Clostridium difficile infection (CDI), sponsored by Pfizer. Started Jul 2018; status: completed.
02
Drugs
Clostridium difficile vaccine
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT03579459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03579459.